Mark R Pittelkow
Overview
Explore the profile of Mark R Pittelkow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
195
Citations
2718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang N, Stockard A, Leibovit-Reiben Z, Hwang A, Kechter J, Brumfiel C, et al.
Arch Dermatol Res
. 2025 Feb;
317(1):413.
PMID: 39951132
Current validated lichen planus (LP) scoring systems are complicated and optimized for generalized, multi-site disease. There is a need for a validated, simple lesional assessment in LP. Herein, we repurpose...
2.
Nassir S, Yousif M, Li X, Severson K, Hughes A, Kechter J, et al.
J Invest Dermatol
. 2025 Jan;
PMID: 39884456
Cutaneous squamous cell carcinoma is one of the most common cancers in humans and kills as many people annually as melanoma. The understanding of the transcriptional changes with respect to...
3.
Hwang A, Kechter J, Do T, Hughes A, Zhang N, Li X, et al.
J Clin Invest
. 2024 Nov;
135(2.
PMID: 39541169
BACKGROUNDCutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor that...
4.
Severson K, Morken C, Nelson S, Mangold A, Pittelkow M, Swanson D
JAAD Case Rep
. 2024 Nov;
53:105-108.
PMID: 39493363
No abstract available.
5.
Hughes A, Li X, Lehman J, Nelson S, DiCaudo D, Mudappathi R, et al.
JID Innov
. 2024 Oct;
4(6):100296.
PMID: 39391813
Drug repurposing is an attractive strategy for therapy development, particularly in rare diseases where traditional drug development approaches may be challenging owing to high cost and small numbers of patients....
6.
Pazhava A, Kim Y, Jing F, Pittelkow M
Int J Dermatol
. 2024 Aug;
64(3):563-570.
PMID: 39154363
Background: Cutaneous melanoma (CM) is a significant health concern because of its high metastatic potential. Gene Expression Profile (GEP) testing, particularly the 31-GEP test (DecisionDx-Melanoma), has been increasingly used for...
7.
Heil P, Pittelkow M, Weaver A, Killian J, Sokumbi O, Wetter D
Int J Dermatol
. 2024 May;
63(8):e148-e156.
PMID: 38727096
Background: We aimed to investigate the prevalence of skin disease among patients with systemic lupus erythematosus (SLE) and determine whether LE skin disease had clinical or serologic correlates with SLE....
8.
Hwang A, Kechter J, Do T, Hughes A, Zhang N, Li X, et al.
medRxiv
. 2024 Jan;
PMID: 38260663
Background: Cutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor...
9.
Shahin A, Greene A, Reeder C, Costello C, Pittelkow M, DiCaudo D
JAAD Case Rep
. 2023 Nov;
41:110-112.
PMID: 37920700
No abstract available.
10.
Hwang A, Hoss E, Pittelkow M, Yang Y
JAMA Dermatol
. 2023 Sep;
159(11):1277-1279.
PMID: 37728912
No abstract available.